Sektorale Bewertungen Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Aktien
ROVI
ES0157261019
ROVI
Pharmazeutika
|
Schlusskurs
Wiener Boerse
01.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 57.65 EUR | -3.11% |
|
-3.27% | -8.93% |
| 23.07. | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23.07. | Laboratorios Farmaceuticos Rovi, S.A. legt Ergebnisse für das Halbjahr bis zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| KGV (Y) | Price to Book (Y) | PEG (Y) | EV / Umsatz (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Dividendenrendite (Y) | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 32.45x | 20.64x | 0.61x | 11.78x | 23.93x | 25.25x | 0.61% | 1’019 Mrd. | |
| 28.48x | 7.15x | -1.54x | 6.32x | 17.7x | 19.9x | 2.09% | 617 Mrd. | |
| 33.26x | -478.61x | 0.14x | 7.78x | 16.08x | 16.76x | 2.64% | 464 Mrd. | |
| 104.98x | 7.35x | -1.29x | 5.87x | 24.89x | 32.86x | 2.36% | 356 Mrd. | |
| 18.81x | 6.87x | 1.29x | 4.58x | 11.36x | 12.59x | 2.9% | 333 Mrd. | |
| 19.83x | 5.63x | -10.65x | 5.17x | 12.78x | 13.65x | 3.09% | 267 Mrd. | |
| 20.02x | 4.51x | 1x | 4.17x | 11.86x | 12.48x | 2.13% | 244 Mrd. | |
| 25.46x | 19.26x | 2.26x | 6.66x | 11.86x | 15.29x | 2.5% | 218 Mrd. | |
| -43.78x | 10.78x | 0.29x | 6.39x | 24.97x | 60.57x | 2.27% | 179 Mrd. | |
| 11.16x | 4.66x | -3.45x | 4.06x | 8.44x | 9.88x | 4.51% | 166 Mrd. | |
| 17.53x | 1.81x | 1.06x | 3.31x | 8.47x | 9.64x | 6.19% | 158 Mrd. | |
| 51.87x | 8.19x | -1.42x | 9.24x | 31.67x | 25.49x | -.--% | 128 Mrd. | |
| 10.89x | 5.13x | 0.17x | 3.08x | 8.02x | 8.64x | 4.13% | 125 Mrd. | |
| 23.13x | -43.9x | 13.98x | 0.25x | 14.56x | 15.57x | 0.4% | 105 Mrd. | |
| 11.27x | 1.15x | -6.28x | 2.03x | 6.57x | 7.27x | 6.01% | 95.48 Mrd. | |
| 13.81x | 4.4x | -1.59x | 2.73x | 8.07x | 8.98x | 3.91% | 94.34 Mrd. | |
| -22.65x | 13.02x | -1.46x | 34.36x | -22.33x | -20.72x | -.--% | 75.86 Mrd. | |
| 16.75x | 2.23x | 2.89x | 3.88x | 9.16x | 10.63x | 0.53% | 73.41 Mrd. | |
| 23.18x | 1.95x | -14.8x | 3.13x | 10.94x | 18.19x | 1.72% | 66.99 Mrd. | |
| Durchschnitt | 20.87x | -20.94x | -0.99x | 6.57x | 12.58x | 15.94x | 2.53% | 251.87 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | 28.44x | -38.30x | -0.64x | 7.20x | 16.55x | 19.58x | 2.22% |
- Börse
- Aktien
- A0M0GQ Aktie
- ROVI Aktie
- Sektor Laboratorios Farmaceuticos Rovi, S.A.
- Sektorale Bewertungen
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
